Impact of clonal hematopoiesis on cardiovascular outcomes in cancer patients of the UK Biobank
CHIP mutations and mCAs are prevalent in cancer patients and are associated with significant increases in cardiovascular risk and mortality, with variations across cancer types. These findings underscore the importance of considering clonal hematopoiesis in the clinical management of cancer patients to mitigate cardiovascular risks.
Authors
- Amina Barhdadi
- Marie‐Pierre Dubé (ORCID: https://orcid.org/0000-0001-8442-4393)
- Lambert Busque (ORCID: https://orcid.org/0000-0002-5375-3749)
- Marilyn Cyr (ORCID: https://orcid.org/0000-0003-1605-0427)
- Louis‐Philippe Lemieux Perreault (ORCID: https://orcid.org/0000-0001-7423-0958)
- Maxine Sun (ORCID: https://orcid.org/0000-0002-7116-8674)
- Johanna Sandoval (ORCID: https://orcid.org/0000-0002-7543-2188)
- J.‐C. Tardif
Institutions
- Montreal Heart Institute (CA)
- Hôpital Maisonneuve-Rosemont (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- ESMO Open
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1016/j.esmoop.2025.105539
- Citations
- 3
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 5.31